Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a Study of Inhaled NOC-100 (NTX-1175) in Adults with Chronic or Acute Cough, including Postinfectious COVID-19 Cough
2020-004715-27Phase 2Completed
- Sponsor
- Nocion Therapeutics
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic cough, acute cough and postinfectious cough comparing NOC-100 inhalation with Placebo inhalation (2 arms). Primary endpoint: Part 1 primary endpoints. Started Dec 2020; status: completed.
02
Drugs
taplucainium chloride
03
Conditions
chronic coughacute coughpostinfectious cough
Beyond the preview
Go deeper on 2020-004715-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004715-27.